{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T05:57:10Z","timestamp":1774245430669,"version":"3.50.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Juvenile systemic sclerosis (jSSc) is a rare, chronic, autoimmune disease in children\/adolescents and is associated with significant morbidity, skin thickening\/hardening (scleroderma), organ toxicity and sub-optimal therapeutic options. In this report, autologous stem cell transplantation is associated with clinical improvement in a 17-year-old with refractory jSSc.<\/jats:p>","DOI":"10.1093\/stcltm\/szag005","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T04:41:19Z","timestamp":1774240879000},"source":"Crossref","is-referenced-by-count":0,"title":["Autologous stem cell transplant for severe, progressive juvenile systemic sclerosis"],"prefix":"10.1093","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1176-8952","authenticated-orcid":false,"given":"Shaikha","family":"Alqahtani","sequence":"first","affiliation":[{"name":"Pediatric Transplant and Cellular Therapy, Duke University , Durham, NC 27705,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Cacace","sequence":"additional","affiliation":[{"name":"Pediatric Transplant and Cellular Therapy, Duke University , Durham, NC 27705,","place":["United States"]},{"name":"Hematopoietic Cell Transplantation and Cellular Therapies Unit, AORN Santobono-Pausilipon , Naples,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4220-3123","authenticated-orcid":false,"given":"Andrea","family":"Bauchat","sequence":"additional","affiliation":[{"name":"Pediatric Transplant and Cellular Therapy, Duke University , Durham, NC 27705,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany Paige","family":"DePriest","sequence":"additional","affiliation":[{"name":"Pediatric Transplant and Cellular Therapy, Duke University , Durham, NC 27705,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy Alan","family":"Driscoll","sequence":"additional","affiliation":[{"name":"Pediatric Transplant and Cellular Therapy, Duke University , Durham, NC 27705,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmem","family":"Bonfim","sequence":"additional","affiliation":[{"name":"Pediatric Transplant and Cellular Therapy, Duke University , Durham, NC 27705,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3370-0703","authenticated-orcid":false,"given":"Joanne","family":"Kurtzberg","sequence":"additional","affiliation":[{"name":"Pediatric Transplant and Cellular Therapy, Duke University , Durham, NC 27705,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Larrier","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Duke University , Durham, NC 27703,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery","family":"Dvergsten","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Duke University , Durham, NC 27703,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris Michael","family":"Mahadeo","sequence":"additional","affiliation":[{"name":"Pediatric Transplant and Cellular Therapy, Duke University , Durham, NC 27705,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"2026032301122317200_szag005-B1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.22551","article-title":"The Pediatric Rheumatology European Society\/American College of Rheumatology\/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis","volume":"57","author":"Zulian","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2026032301122317200_szag005-B2","doi-asserted-by":"crossref","first-page":"4569826","DOI":"10.1155\/2019\/4569826","article-title":"Systemic sclerosis pathogenesis and emerging therapies, beyond the fibroblast","volume":"2019","author":"Sierra-Sep\u00falveda","year":"2019","journal-title":"Biomed Res Int"},{"key":"2026032301122317200_szag005-B3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/2397198318763701","article-title":"Assessing the prevalence of juvenile systemic sclerosis in childhood using administrative claims data from the United States","volume":"3","author":"Beukelman","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"key":"2026032301122317200_szag005-B4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.rdc.2021.07.004","article-title":"Updates in systemic sclerosis treatment and applicability to pediatric scleroderma","volume":"47","author":"Torok","year":"2021","journal-title":"Rheum Dis Clin North Am"},{"key":"2026032301122317200_szag005-B5","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1002\/art.22207","article-title":"Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database","volume":"54","author":"Martini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2026032301122317200_szag005-B6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/rheumatology\/keaa584","article-title":"Consensus-based recommendations for the management of juvenile systemic sclerosis","volume":"60","author":"Foeldvari","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2026032301122317200_szag005-B7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3892\/etm.2021.11057","article-title":"Old and new therapeutic strategies in systemic sclerosis (review)","volume":"23","author":"Bobeica","year":"2022","journal-title":"Exp Ther Med"},{"key":"2026032301122317200_szag005-B8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3324\/haematol.2019.230128","article-title":"Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party","volume":"106","author":"Henes","year":"2021","journal-title":"Haematologica"},{"key":"2026032301122317200_szag005-B9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"key":"2026032301122317200_szag005-B10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"key":"2026032301122317200_szag005-B11","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1038\/s41409-021-01355-1","article-title":"Long term outcomes of the French ASTIS systemic sclerosis cohort using the global rank composite score","volume":"56","author":"Ait Abdallah","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"2026032301122317200_szag005-B12","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004381","article-title":"Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children","volume":"10","author":"Satirer","year":"2024","journal-title":"RMD Open"},{"key":"2026032301122317200_szag005-B13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/23971983241293297","article-title":"What are Juvenile-onset systemic sclerosis providers thoughts, experiences, and reasons for autologous stem cell transplant? Result of a multinational survey","volume":"10","author":"Foeldvari","year":"2024","journal-title":"J Scleroderma Relat Disord"},{"key":"2026032301122317200_szag005-B14","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2026032301122317200_szag005-B15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbmt.2018.01.020","article-title":"Autologous hematopoietic stem cell transplantation for systemic sclerosis: a systematic review and meta-analysis","volume":"24","author":"Shouval","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"2026032301122317200_szag005-B16","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bmt.2011.185","article-title":"Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European group for blood and marrow transplantation","volume":"47","author":"Snowden","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"2026032301122317200_szag005-B17","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"key":"2026032301122317200_szag005-B18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/rheumatology\/38.8.773","article-title":"Marked and sustained improvement 2 years after autologous stem cell transplantation in a girl with systemic sclerosis","volume":"38","author":"Martini","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"2026032301122317200_szag005-B19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11926-000-0069-8","article-title":"Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease","volume":"2","author":"Wulffraat","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"2026032301122317200_szag005-B20","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1182\/blood-2022-167533","article-title":"Autologous Stem Cell Transplantation (ASCT) for refractory Juvenile-Onset systemic sclerosis (jSSc) is safe and well tolerated and improves clinical and patient-reported outcomes","volume":"140","author":"Barnum","year":"2022","journal-title":"Blood"},{"key":"2026032301122317200_szag005-B21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/1744666X.2025.2474216","article-title":"Guidance for stem cell therapy for juvenile systemic sclerosis patients","volume":"21","author":"Foeldvari","year":"2025","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/15\/4\/szag005\/67473939\/szag005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/15\/4\/szag005\/67473939\/szag005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T05:12:28Z","timestamp":1774242748000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/doi\/10.1093\/stcltm\/szag005\/8537332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,23]]}},"URL":"https:\/\/doi.org\/10.1093\/stcltm\/szag005","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,23]]},"article-number":"szag005"}}